FDA approves updated COVID boosters, but narrows use
Written by
BioPharma Dive
Published
0
comments
0
min
While the agency cleared vaccines from Pfizer, Moderna and Novavax broadly in older adults, it restricted eligibility in younger people to those with underlying health conditions.